Ligand Pharmaceuticals Stock Forecast

Stock Price Forecast

The 1 analyst with a 12-month price forecast for Ligand Pharmaceuticals stock has a target of 9.00, which predicts a 105.01% increase from the current stock price of 4.39.

Price Target: $9.00 (+105.01%)

Analyst Consensus: Strong Buy

Target	Low	Average	Median	High
Price	$9.00	$9.00	$9.00	$9.00
Change	+105.01%	+105.01%	+105.01%	+105.01%

* Price targets were last updated on Jun 16, 2025.

Analyst Ratings

According to 1 stock analyst, the rating for Ligand Pharmaceuticals is "Strong Buy". This means that the analyst believes this stock is likely to perform very well in the near future and significantly outperform the market.

Recommendation Trends

Rating	Jun '25	Jul '25
Strong Buy	1	1
Buy	0	0
Hold	0	0
Sell	0	0
Strong Sell	0	0
Total	1	1

Latest Forecasts

Analyst	Firm	Rating	Rating	Action	Price Target	Upside	Date
Matthew Galinko Maxim Group	Maxim Group	Strong Buy Initiates $9	Strong Buy	Initiates	$9	+105.01%	Jun 16, 2025

More Analyst Ratings

Financial Forecast

Revenue This Year

n/a

from 1.96M

Revenue Next Year

n/a

EPS This Year

n/a

from -0.18

EPS Next Year

n/a

Fiscal Year	FY 2021	FY 2022	FY 2023	FY 2024
Period Ending	Dec 31, 2021	Dec 31, 2022	Dec 31, 2023	Dec 31, 2024
Revenue	2.29M	3.03M	1.83M	1.96M
Revenue Growth	-	32.36%	-39.59%	7.43%
EPS	-0.01	0.00	-0.01	-0.18
EPS Growth	-	-	-	-
Forward PE	-	-	-	-
No. Analysts	-	-	-	-

Financial currency is CAD. Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.

Revenue Forecast

No data available

Revenue Growth

No data available

EPS Forecast

No data available

EPS Growth

No data available

Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.